These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4800460)

  • 41. Experimental autoimmune glomerulonephritis in the rat. I. Factors influencing induction.
    McCausland IP; Herdson PB; Gavin JB
    Pathology; 1976 Apr; 8(2):109-15. PubMed ID: 972769
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Experimental autoimmune glomerulonephritis with pulmonary hemorrhage in rats. The dose-effect relationship of the nephritogenic antigen from bovine glomerular basement membrane.
    Sado Y; Okigaki T; Takamiya H; Seno S
    J Clin Lab Immunol; 1984 Dec; 15(4):199-204. PubMed ID: 6527375
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Indomethacin in the treatment of glomerulonephritis].
    Tomilina NA; Biriukova LS
    Sov Med; 1983; (9):104-6. PubMed ID: 6648668
    [No Abstract]   [Full Text] [Related]  

  • 44. Effect of a novel immunosuppressant, FK 506, on autoimmune glomerulonephritis in Brown Norway rats.
    Nakahama H; Obata K; Matsuyama T; Sugita M; Horio M; Oka K; Moriyama T
    Nephron; 1999 Feb; 81(2):215-20. PubMed ID: 9933758
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Immunopathogenesis of different forms of glomerulonephritis. Possible indications for immunosuppressive therapy].
    Rother K
    Med Klin; 1971 Mar; 66(13):457-68. PubMed ID: 4934215
    [No Abstract]   [Full Text] [Related]  

  • 46. [Treatment of kidney diseases with non-steroid anti-inflammatory drugs. I. Antiproteinuric effects of indomethacin].
    Hamada A
    Nihon Jinzo Gakkai Shi; 1975 Dec; 17(12):973-94. PubMed ID: 1241989
    [No Abstract]   [Full Text] [Related]  

  • 47. Possibilities and limitations of production of autoimmune diseases in inbred mouse strains.
    Boehme DH
    Pathol Eur; 1966; 1(1):119-34. PubMed ID: 5990935
    [No Abstract]   [Full Text] [Related]  

  • 48. Effect of hypertension on experimental glomerulonephritis in rats.
    Iversen BM; Ofstad J
    Lab Invest; 1984 Feb; 50(2):163-73. PubMed ID: 6694357
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Clinical and basic studies on immunosuppressive agents in renal disease].
    Nihon Jinzo Gakkai Shi; 1993 May; 35(5):438-45. PubMed ID: 8361092
    [No Abstract]   [Full Text] [Related]  

  • 50. RENAL CHANGES IN THE RAT FOLLOWING INTRAVENOUS INJECTION OF COMPLETE FREUND'S ADJUVANT.
    CUPPAGE FE
    Lab Invest; 1965 May; 14():514-28. PubMed ID: 14286385
    [No Abstract]   [Full Text] [Related]  

  • 51. [The possible approaches to the theoretical validation of the use of cytostatics and corticosteroids in treating glomerulonephritis].
    Ivanov AA; Shilov EM; Gladskikh OP; Krasnova TN; Karpukhin VV; Gitel' EP; Pal'tsev MA
    Ter Arkh; 1993; 65(6):23-6. PubMed ID: 8378841
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The pharmacological therapy of glomerulonephritis].
    Cinotti GA; Comunian C
    Ann Ital Med Int; 1993; 8(2):108-12. PubMed ID: 8353018
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Pneumocystis carinii and aspergillus pneumonia in immunosuppression in rapidly progressing glomerulonephritis of the anti-glomerular basement membrane type].
    Späth M; Schollmeyer P
    Med Klin (Munich); 1996 Sep; 91(9):603-6. PubMed ID: 8984320
    [No Abstract]   [Full Text] [Related]  

  • 54. NK026680, a novel suppressant of dendritic cell function, prevents the development of rapidly progressive glomerulonephritis and perinuclear antineutrophil cytoplasmic antibody in SCG/Kj mice.
    Saiga K; Tokunaka K; Ichimura E; Toyoda E; Abe F; Yoshida M; Furukawa H; Nose M; Ono M
    Arthritis Rheum; 2006 Nov; 54(11):3707-15. PubMed ID: 17075885
    [TBL] [Abstract][Full Text] [Related]  

  • 55. RESPIRATION OF RAT KIDNEY CORTEX SLICES IN EXPERIMENTAL PROTEINURIA AND RENALE DISEASE.
    KMETEC E; HEYMANN W; CUPPAGE F; LEWY P
    Lab Invest; 1964 Mar; 13():272-81. PubMed ID: 14130191
    [No Abstract]   [Full Text] [Related]  

  • 56. [Indomethacin in the therapy of prolonged or chronic glomerulonephritis and of the nephrotic syndrome].
    Campanacci L; Gambari P; Castellani A; Huber W
    Clin Ter; 1972 Apr; 61(1):31-46. PubMed ID: 5039599
    [No Abstract]   [Full Text] [Related]  

  • 57. The temporal relationship of complement-fixing antibrain and tuberculin type sensitivity in experimental allergic encephalomyelitis.
    Greifenkamp J; Bartel AH; Fahlberg WJ
    Ann Allergy; 1970 Nov; 28(11):522-7. PubMed ID: 5521183
    [No Abstract]   [Full Text] [Related]  

  • 58. [Indomethacin in nephropathies in children. Apropos of 21 cases].
    Pierron H; Manassero J; Vaillaud JC; Paglia R; Orsini A
    Pediatrie; 1971 Mar; 26(2):167-73. PubMed ID: 5554434
    [No Abstract]   [Full Text] [Related]  

  • 59. [Indomethacin in therapy of proteinuria in glomerulonephritis].
    Renner E; Held E
    Arzneimittelforschung; 1971 Nov; 21(11):1849-51. PubMed ID: 5171820
    [No Abstract]   [Full Text] [Related]  

  • 60. Treatment of experimental immune complex glomerulonephritis by sodium alginate.
    Mirshafiey A; Borzooy Z; Abhari RS; Razavi A; Tavangar M; Rehm BH
    Vascul Pharmacol; 2005 Jun; 43(1):30-5. PubMed ID: 15893960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.